Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.

  • days left to enroll
  • participants needed
  • sponsor
    Centre Oscar Lambret
Updated on 29 October 2021
squamous cell carcinoma


This is a monocentric, prospective, non-comparative phase II study with minimal risks and constraints. The study will aim to assess the curative treatment of radio-induced mucositis by photobiomodulation using LED lamp.


The aim of this study is to assess the effectiveness of the treatment of radio- or radio-chemotherapy-induced early stage mucositis (stage 1 and 2) by photobiomodulation using LED lamp (PLED) in terms of controlling the mucositis assessed at the end of radiotherapy or radio-chemotherapy treatment.

Other objectives of the study include:

  • To assess the pain evolution over-time, both overall over the evaluation period until the end of radiotherapy and at each session
  • To assess the needs of level 3 analgesics (morphine, oxycodone, fentanyl, hydromorphone) during the PLED protocol.
  • To assess the quality of life variation between inclusion and the end of treatment by radiotherapy or radio-chemotherapy.
  • To estimate the frequency of radiotherapy or radio-chemotherapy treatment (temporary or permanent interruption, dose modification), and eventually, the reason of this modification.
  • To assess the feasibility of photobiomodumation by LED (PLED) in this context.
  • To assess the tolerability of photobiomodumation by LED (PLED) in a short term.
  • To assess the frequency of the needs of nutritional support by nasogastric tube or gastrostomy tube during the PLED protocol.
  • To assess the weight and general condition variation during the treatment.

Condition Oropharyngeal Cancer, carcinoma of oropharynx, Oral Cavity Cancer, oropharyngeal carcinoma, Head and Neck Cancer, head and neck cancer, oral cancers, Oral Neoplasm, cancer, oropharynx, Oral Cancer
Treatment LED photobiomodulation
Clinical Study IdentifierNCT04251949
SponsorCentre Oscar Lambret
Last Modified on29 October 2021


Yes No Not Sure

Inclusion Criteria

Age > 18 years old
With squamous cell carcinoma of the head and/or neck
Stage 1 or 2 mucositis (NCI-CTCAE v5), wich means a mucositis not requiring an enteral nutrition management (solid or liquid alimentation possible, including with feed supplements) in week 2 to 4 in relation to the beginning of radiotherapy
During treatment by radiotherapy, with or without concomitant chemotherapy
Patient affiliated to a social security system
Patient who signed the informed consent for this study

Exclusion Criteria

Radiotherapy treatment completed
Stage 3 or higher mucositis already installed
History of skin porphyria or lupus erythematosus
Concomitant or within 7 days prior to inclusion, at least one of following drugs : fluoroquinolones, cycline, methotrexate, auranofine
Enteral nutrition support in progress
Pregnant or breast-feeding woman
Patient under guardianship or curatorship
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note